Synthetic protein antigens for COVID-19 diagnostics
Schein, C. H.; McClellan, S. F.; Levine, C. B.; Negi, S. S.; Braun, W.; Dreskin, S.; Anaya, E. S.; Schmidt, J.
Show abstract
There is an urgent need for inexpensive, rapid and specific antigen-based assays to test for infection with SARS-CoV-2 and distinguish variants arising as the COVID-19 pandemic spreads. We have identified a small, synthetic protein (JS7), representing a region of maximum variability within the receptor binding domain (RBD), which binds antibodies in sera from nine patients with PCR-verified COVID-19 of varying severity. Antibodies binding to either JS7 or the SARS-CoV-2 recombinant RBD, as well as those that disrupt binding between a fragment of the ACE2 receptor and the RBD, are proportional to disease severity and clinical outcome. Binding to JS7 was inhibited by linear peptides from the RBD interface with ACE2. Variants of JS7, such as N501Y, can be quickly synthesized in a pure form in large quantities by automated methods. JS7 and related synthetic antigens can provide a basis for specific diagnostics for SARS-CoV-2 infections.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19 95%
- No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor 94%
- Reduced serum neutralization capacity against SARS-CoV-2 variants in a multiplex ACE2 RBD competition assay 93%
Similar papers in this journal
- SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface 94%
- Tiger team: a panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes 94%
- Glycan remodeled erythrocytes facilitate antigenic characterizationof recent A/H3N2 influenza viruses 94%
Similar papers in this journal
- Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment 95%
- The SARS-CoV-2 Y453F mink variant displays a striking increase in ACE-2 affinity but does not challenge antibody neutralization 93%
- Sialic Acid Identity Modulates Host Tropism of Sialoglycan-binding Viridans Group Streptococci 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.